The Study of the Possibility of Creating Intranasal Dosage Forms With the Phytocomplex of Ginkgo Biloba and Their Analysis

Abstract

Abstract. One of the important tasks of modern pharmaceutical technology is the creation of effective and safe medicines that meet modern requirements and realities. And, as a result, having a minimum of side effects. Stressful situations associated with a stressful rhythm of life, past illnesses and many other factors contribute to a significant increase in the number of patients with cerebral circulatory disorders. That is why the search for new effective medicines and more universal dosage forms capable of restoring or compensating for impaired brain functions is timely and relevant. There are enough drugs with such activity, but there are not so many containing phytocomplexes. That is why the choice of objects of plant origin that occupy a special niche in the group and have an impact on cerebral circulation and on the condition of blood vessels seems promising to us Models constructed on the basis of the ginkgo biloba phytocomplex fit into this problem in all indicators – pharmacological, technological and economic. In addition, there is a sufficient raw material base. Analysis of the literature data has shown that drugs in the form of intranasal dosage forms intended to improve cerebral circulation will be promising drugs aimed at a wide range of consumers. Therefore, research in this area is appropriate and will have wide practical application in the future. The purpose of this study is the development of intranasal pharmaceutical farms and their standardization.